NCT04631601 2025-10-07Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)AmgenPhase 1/2 Terminated65 enrolled
NCT00103376 2018-11-05Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate CancerMedical University of South CarolinaPhase 2 Terminated23 enrolled 9 charts